T-Therapeutics and Alethio Therapeutics – have raised $133 million and $90 million, respectively, in an impressive pair of ...

Patients with muscle-invasive bladder cancer can now receive NHS treatment with a regimen of MSD's Keytruda and Astellas' ...

One of the things I enjoyed most about this year’s PM Society PMi Awards was the sheer breadth of the community in the room.

In oncology, time is not simply a measure of care; it is a clinical variable – and increasingly a therapeutic challenge.

Across events and general day-to-day industry updates, one term has dominated market access conversations in 2026: Most Favoured Nation. Now, debates over pricing in the US are nothing new – far from ...

The one-year-old start-up is the latest to receive financial backing from the UK government's £500 million Sovereign AI ...

Theramex, a London, UK-based specialty pharma company focusing on women's health, is changing hands in a deal reportedly ...

Businesses are finding that AI is a great leveller. Organisations with mature digital infrastructures can use AI to unlock ...

Novo has raised its financial guidance for 2026 on the back of rising sales of its oral weight-loss therapy Wegovy, which ...

As an oncologist with more than 25 years of experience across clinical care, research, drug and device development, and ...

The BioInnovation Institute (BII) has expanded a network striving to develop treatments for cardiometabolic diseases and ...

Hard on the heels of a £1 billion investment package by pharma companies in last week's UK Budget, AbbVie has pledged another ...